149 Results
Position Statement on Relationship Between Treatment and Mutual Support
Position Statement on Relationship Between Treatment and Mutual Support
Position Statement on Reducing the Burden of Treatment Plan Documentation
Position Statement on Reducing the Burden of Treatment Plan Documentation
Position Statement on Out of Network Restriction of Psychiatrists
Position Statement on Out of Network Restriction of Psychiatrists
Position Statement on Level of Care Criteria for Acute Psychiatric Treatment
Position Statement on Level of Care Criteria for Acute Psychiatric Treatment
Position Statement on Carve Outs and Discrimination
Position Statement on Carve Outs and Discrimination
Consensus statement on "Managing the risks of repetitive transcranial stimulation"
In response to the changing managed care environment, the APA Committee on Managed Care established a subcommittee to document the changes in managed care and to begin the process of thinking about alternative healthcare financing systems. The Committee undertook writing a resource document for APA members to identify and describe the changes that are occurring in the healthcare sector and to prepare them for changes that may occur so that psychiatry can be proactive in meeting these challenges
Position Statement on Second Generation Antipsychotic Medications
Position Statement on Second Generation Antipsychotic Medications
Position Statement on Ensuring Access to, and Appropriate Utilization of, Psychiatric Services for the Elderly
Position Statement on Ensuring Access to, and Appropriate Utilization of, Psychiatric Services for the Elderly
Position Statement on Discriminatory Disability Insurance Coverage
Position Statement on Discriminatory Disability Insurance Coverage
Position Statement on Banning of Pharmacy Benefit Management Policies that Require the Provision of Dangerous Quantities of Medications
Position Statement on Banning of Pharmacy Benefit Management Policies that Require the Provision of Dangerous Quantities of Medications
Position Statement on Prior Authorizations for Psychotropic Medications
Position Statement on Prior Authorizations for Psychotropic Medications
Safe Consumption Facilities
In 2019, there were nearly 72,000 U.S. overdose deaths, a new record high. Most of these overdose deaths involved opioids, with rising involvement of fentanyl and fentanyl analogues, which are increasingly found in street heroin and other opioids and often without the knowledge of the user. Even more concerning, it appears that the coronavirus pandemic is further worsening the overdose crisis.1 In the context of this ongoing crisis, psychiatrists must be aware of the full range of policy, organi